AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-1.48%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$393M
AUM Growth
+$393M
(+6.9%)
Cap. Flow
+$29.3M
Cap. Flow
% of AUM
7.44%
Top 10 Holdings %
Top 10 Hldgs %
80.79%
Holding
223
New
14
Increased
86
Reduced
51
Closed
29
Top Buys
| 1 |
iShares MBS ETF
MBB
|
$10.8M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$10.1M |
| 3 |
Seres Therapeutics
MCRB
|
$1.15M |
| 4 |
Vuzix
VUZI
|
$1.05M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$997K |
Top Sells
| 1 |
Ouster
OUST
|
$1.06M |
| 2 |
GE Aerospace
GE
|
$1.01M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$998K |
| 4 |
Travere Therapeutics
TVTX
|
$897K |
| 5 |
ADC Therapeutics
ADCT
|
$633K |
Sector Composition
| 1 | Real Estate | 18.05% |
| 2 | Healthcare | 12.08% |
| 3 | Technology | 1.59% |
| 4 | Financials | 1.03% |
| 5 | Industrials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares MBS ETF
MBB
$41B
| $142M | 36% | 1,310,000 +100,000 | +8% | +$10.8M |
|
|
2
Vanguard Mortgage-Backed Securities ETF
VMBS
$14.7B
| $101M | 25.66% | 1,895,000 +190,000 | +11% | +$10.1M |
|
3
Invitation Homes
INVH
$19.2B
| $32.7M | 8.32% | 854,144 | – | – |
|
4
American Homes 4 Rent
AMH
$13.3B
| $30.8M | 7.82% | 806,924 | – | – |
|
5
Rithm Capital
RITM
$6.57B
| $2.7M | 0.69% | 245,158 | – | – |
|
6
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $2.04M | 0.52% | 23,625 +8,565 | +57% | +$738K |
|
7
Stereotaxis
STXS
$261M
| $1.88M | 0.48% | 350,000 +25,000 | +8% | +$135K |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $1.86M | 0.47% | 10,250 +3,000 | +41% | +$544K |
|
9
Intuitive Surgical
ISRG
$170B
| $1.74M | 0.44% | 1,750 -250 | -13% | -$249K |
|
10
Galapagos
GLPG
$2.07B
| $1.55M | 0.39% | 29,500 +8,000 | +37% | +$421K |
|
11
Azenta
AZTA
$1.4B
| $1.54M | 0.39% | 15,000 | – | – |
|
12
Synopsys
SNPS
$112B
| $1.5M | 0.38% | 5,000 -500 | -9% | -$150K |
|
13
Omnicell
OMCL
$1.5B
| $1.48M | 0.38% | 10,000 | – | – |
|
14
AeroVironment
AVAV
$12.1B
| $1.3M | 0.33% | 15,000 | – | – |
|
15
Ametek
AME
$42.7B
| $1.24M | 0.32% | 10,000 | – | – |
|
|
16
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.22M | 0.31% | 73,500 +60,000 | +444% | +$997K |
|
|
MOR
17
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.19M | 0.3% | 101,000 +55,500 | +122% | +$653K |
|
18
Allient
ALNT
$769M
| $1.17M | 0.3% | 37,500 | – | – |
|
|
OYST
19
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $1.17M | 0.3% | 98,500 +62,000 | +170% | +$735K |
|
20
Novanta
NOVT
$4.19B
| $1.16M | 0.29% | 7,500 | – | – |
|
|
21
Seres Therapeutics
MCRB
$166M
| $1.15M | 0.29% | +165,500 | New | +$1.15M |
|
22
Cogent Biosciences
COGT
$1.69B
| $1.13M | 0.29% | 134,475 +11,975 | +10% | +$101K |
|
|
EFC
23
Ellington Financial
EFC
$1.36B
| $1.1M | 0.28% | 60,283 +28,283 | +88% | +$517K |
|
24
BioXcel Therapeutics
BTAI
$59M
| $1.06M | 0.27% | 35,000 +10,000 | +40% | +$303K |
|
25
Incyte
INCY
$16.5B
| $1.05M | 0.27% | 15,250 +11,250 | +281% | +$774K |
|